Back to Journals » OncoTargets and Therapy » Volume 9

Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report

Total article views   HTML views PDF downloads Totals
7,460 Dovepress* 6,145+ 1,301 7,446
PubMed Central* 1,315 380 1,695
Totals 7,460 1,681 9,141
*Since 1 July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed and Google Scholar